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Summary
Background Prosthetic joint infection is a devastating complication of knee replacement. The risk of developing a 
prosthetic joint infection is affected by patient, surgical, and health-care system factors. Existing evidence is limited 
by heterogeneity in populations studied, short follow-up, inadequate power, and does not differentiate early prosthetic 
joint infection, most likely related to the intervention, from late infection, more likely to occur due to haematogenous 
bacterial spread. We aimed to assess the overall and time-specific associations of these factors with the risk of revision 
due to prosthetic joint infection following primary knee replacement.
Methods In this cohort study, we analysed primary knee replacements done between 2003 and 2013 in England and 
Wales and the procedures subsequently revised for prosthetic joint infection between 2003 and 2014. Data were obtained 
from the National Joint Registry linked to the Hospital Episode Statistics data in England and the Patient Episode 
Database for Wales. Each primary replacement was followed for a minimum of 12 months until the end of the observation 
period (Dec 31, 2014) or until the date of revision for prosthetic joint infection, revision for another indication, or death 
(whichever occurred first). We analysed the data using Poisson and piecewise exponential multilevel models to assess the 
associations between patient, surgical, and health-care system factors and risk of revision for prosthetic joint infection.
Findings Of 679 010 primary knee replacements done between 2003 and 2013 in England and Wales, 3659 were 
subsequently revised for an indication of prosthetic joint infection between 2003 and 2014, after a median follow-up of 
4·6 years (IQR 2·6–6·9). Male sex (rate ratio [RR] for male vs female patients 1·8 [95% CI 1·7–2·0]), younger age (RR for 
age ≥80 years vs <60 years 0·5 [0·4–0·6]), higher American Society of Anaesthesiologists [ASA] grade (RR for ASA 
grade 3–5 vs 1, 1·8 [1·6–2·1]), elevated body-mass index (BMI; RR for BMI ≥30 kg/m² vs <25 kg/m² 1·5 [1·3–1·6]), 
chronic pulmonary disease (RR 1·2 [1·1–1·3]), diabetes (RR 1·4 [1·2–1·5]), liver disease (RR 2·2 [1·6–2·9]), connective 
tissue and rheumatic diseases (RR 1·5 [1·3–1·7]), peripheral vascular disease (RR 1·4 [1·1–1·7]), surgery for trauma 
(RR 1·9 [1·4–2·6]), previous septic arthritis (RR 4·9 [2·7–7·6]) or inflammatory arthropathy (RR 1·4 [1·2–1·7]), operation 
under general anaesthesia (RR 1·1 [1·0–1·2]), requirement for tibial bone graft (RR 2·0 [1·3–2·7]), use of posterior 
stabilised fixed bearing prostheses (RR for posterior stabilised fixed bearing prostheses vs unconstrained fixed bearing 
prostheses 1·4 [1·3–1·5]) or constrained condylar prostheses (3·5 [2·5–4·7]) were associated with a higher risk of revision 
for prosthetic joint infection. However, uncemented total, patellofemoral, or unicondylar knee replacement (RR for 
uncemented vs cemented total knee replacement 0·7 [95% CI 0·6–0·8], RR for patellofemoral vs cemented total knee 
replacement 0·3 [0·2–0·5], and RR for unicondylar vs cemented total knee replacement 0·5 [0·5–0·6]) were associated 
with lower risk of revision for prosthetic joint infection. Most of these factors had time-specific effects, depending on the 
time period post-surgery.
Interpretation We have identified several risk factors for revision for prosthetic joint infection following knee 
replacement. Some of these factors are modifiable, and the use of targeted interventions or strategies could lead to a 
reduced risk of revision for prosthetic joint infection. Non-modifiable factors and the time-specific nature of the effects 
we have observed will allow clinicians to appropriately counsel patients preoperatively and tailor follow-up regimens.
Funding National Institute for Health Research.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Knee replacement is one of the most common elective 
surgical procedures worldwide. The National Joint 
Registry for England, Wales, Northern Ireland and 
the Isle of Man recorded 102 777 knee replacements 
performed in 2017, and the secular trend continues to 
increase.1 Deep infection is a rare but devastating 
complication affecting approxi mately 4% of primary 
and 15% of revision knee replace ments.2 The most 
common causative organisms remain coagulase-negative 
staphylococci and Staphylococcus aureus, which are 
usually sensitive to a range of antibiotics.3 Treatment of 
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prosthetic joint infection is expensive and protracted, 
and both the infection and the treatment have pro-
foundly negative effects on patients and their families.4–7 
Treatment options include antibiotic suppression, 
debridement and retention of implants, excisional 
arthroplasty, and one-stage or two-stage revision.8,9 
However, all of these treatment options are associated 
with substantial morbidity and a high risk of adverse 
outcomes. As knee replacements have become more 
common, the number of revision operations for 
infection between 2005 and 2013 in England and 
Wales has risen by more than threefold, with more than 
1000 revision procedures due to prosthetic joint 
infection of the knee done annually since 2011.10
The risk of developing infection after any form of 
arthroplasty is affected by both modifiable and non-
modifiable patient, surgical, and health-care system 
factors. A recent systematic review of patient risk factors 
for prosthetic joint infection in both hip and knee 
replacements identified male sex, smoking, increasing 
body-mass index (BMI), steroid use, previous joint 
surgery, and comorbidities such as diabetes, rheumatoid 
Research in context
Evidence before this study
Prosthetic joint infection, although a rare complication 
following total joint replacement, is associated with 
devastating consequences. Evidence suggests that the risk of 
developing prosthetic joint infection following total hip or knee 
replacement is likely to be affected by patient-related, 
surgery-related, and health-care system-related factors. 
However, since total hip and knee replacements are two 
different operations involving patients with differing risk 
profiles, whether these factors affect prosthetic joint infection 
rates differentially in these patient groups remains uncertain. 
In a meta-analysis of 66 studies comprising more than 
500 000 total joint replacements and published by our group in 
2016, patient-related factors such as male sex, high body-mass 
index (BMI), steroid use, diabetes, rheumatoid arthritis, 
congestive heart failure, depression, and smoking and alcohol 
intake were each found to be associated with an increased risk 
of prosthetic joint infection. In a single cohort prospective 
study published in September, 2018, and comprising more than 
600 000 primary hip replacements, we confirmed previous 
findings and showed several additional patient factors 
(eg, younger age, chronic pulmonary disease, and liver disease) 
and surgical factors (eg, surgery type, lateral surgical approach, 
and non-ceramic bearing surfaces) to be associated with an 
increased risk of infection. We also demonstrated that these 
factors exhibit specific time effects following surgery. 
However, the evidence for total knee replacements is less 
robust. We searched MEDLINE, Embase, and Web of Science 
from the date of the last search of the 2016 review 
(Sept 1, 2015) up to August, 2018, for observational cohort 
studies and systematic reviews and meta-analyses reporting on 
associations of patient-related, surgery-related, or health-care 
system-related factors with risk of prosthetic joint infection 
following total knee replacement. We used search terms related 
to the exposures (eg, “risk factor”, “body mass index”, and 
“comorbidity”) with those related to prosthetic joint infection 
(eg, “peri-prosthetic joint infection” and “prosthetic joint 
infection”). Our search was not restricted by language. We 
identified several registry studies and a meta-analysis based on 
16 studies, whose findings are consistent with previous work 
on the topic. Existing evidence for the role of patient-related, 
surgery-related, or health-care system-related factors on 
prosthetic joint infection risk following total knee replacement 
is limited by inadequate sample sizes, short follow-up 
durations, inadequate adjustment for confounders, substantial 
inter-study heterogeneity, and inability to account for 
time-specific effects during follow-up.
Added value of this study
Using a single observational cohort of 679 010 primary total knee 
replacements, this study evaluated the overall and time-specific 
associations of patient, surgical, and health-care system factors on 
the risk of revision for prosthetic joint infection. Over a median 
follow-up of 4·6 years, 3659 knees were revised for prosthetic joint 
infection. Patient factors such as male sex, younger age 
(<60 years), high BMI (≥25 kg/m2), chronic pulmonary disease, 
diabetes, liver disease, connective tissue or rheumatic disease, and 
peripheral vascular disease were each associated with an increased 
risk of revision for prosthetic joint infection. Surgical factors such as 
indications for the primary procedure, type of procedure, and 
implant fixation and constraint or bearing significantly affected the 
risk of revision for prosthetic joint infection. Patients who received 
general anaesthesia or a tibial bone graft had an increased risk of 
revision, whereas the risk was lower for those who received a spinal 
anaesthetic. On the role of health-care system characteristics, 
high-volume hospitals had an increased risk of revision for 
prosthetic joint infection and privately funded procedures carried a 
lower risk of revision than operations funded by the NHS. 
Factors such as male sex and younger age had a consistent effect 
during the entire postoperative period, whereas other factors 
(such as indications for the primary procedure, type of procedure, 
and implant fixation and constraint or bearing) exhibited 
time-specific effects on revision for prosthetic joint infection.
Implications of all the available evidence
With the ageing population and a projected increase in total 
knee replacements, the burden of prosthetic joint infection will 
rise proportionately. The development of a prosthetic joint 
infection following total knee replacement is influenced by 
several modifiable and non-modifiable factors, which also seem 
to exhibit time-specific effects. Awareness of these factors and 
their time-specific effects should assist clinicians in appropriate 
counselling of patients preoperatively, optimisation of patients 
before surgery, as well as enhanced monitoring of at-risk 
patients after surgery.
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arthritis, and depression, as notable risk factors for 
infection.11 However, limitations of this study and other 
reviews include short follow-up, pooled estimates based 
on variably adjusted data, and evidence of substantial 
heterogeneity between studies.11,12
In view of these limitations, there is a need for large-
scale cohort studies with adequate power to provide 
evidence about the nature and magnitude of the 
associations of potential risk factors with prosthetic joint 
infection. We recently published one such study about 
infection following hip replacement, which highlighted 
the importance of disentangling the time-specific effects 
of factors associated with early onset of prosthetic joint 
infection that are likely to be the consequence of the 
primary intervention versus factors associated with later 
onset that are more likely to result from haematogenous 
spread.9,13
Although they are often studied together, hip and knee 
osteoarthritis are in some regards very different diseases14 
with varying responses to joint replacement.15 Ortho-
paedic surgeons often specialise in either hip or knee 
replacement, and surgical techniques and implants aim 
to address specific issues relating to joint structure and 
function. Furthermore, patient recovery,16 outcomes,17 
and rates of complications including prosthetic joint 
infection10,18 differ between hip and knee replacement.
In this study, we aimed to assess the overall and post-
operative period-specific associations of patient, surgical, 
and health-care setting factors with the risk of revision 
due to prosthetic joint infection in prospectively collected 
observational data of primary knee replacements done in 
England and Wales. We also aimed to investigate whether 
these factors differed from those associated with revision 
for prosthetic joint infection after hip replacement.
Methods
Study design and data sources
In this observational cohort study, we report analyses of 
data for England and Wales from the National Joint 
Registry for England, Wales, Northern Ireland, and the 
Isle of Man between April 1, 2003, and December 31, 2014. 
Data collection for Northern Ireland and the Isle of Man 
could not be considered due to their low number of 
procedures and insufficient duration of follow-up.
National Joint Registry data were linked to Hospital 
Episode Statistics in England and the Patient Episode 
Database for Wales to obtain data about inpatient and 
day case admissions. Data from the Office for National 
Statistics were linked to obtain the date of death.
Patient consent was obtained for data collection and 
linkage by the National Joint Registry. According to the 
NHS Health Research Authority, separate consent and 
ethics approval were not required for this study.
Procedures
We analysed primary knee replacements done between 
April 1, 2003, and Dec 31, 2013, and revision procedures for 
prosthetic joint infection that occurred after the primary 
replacement between April 1, 2003, and Dec 31, 2014. The 
reason for revision is recorded by clinicians at the time of 
the revision procedure and reflects a clinical judgement 
sufficient to lead the surgeon to do an invasive procedure 
tailored to treat prosthetic joint infection. The diagnosis 
and treatment strategy for prosthetic joint infection is at 
the discretion of the surgeon and treating unit and is 
reflective of con temporary practice during the study 
period, with raised inflammatory markers, joint-specific 
symptoms, sinuses, and positive microbiological cultures19 
being common diagnostic features during that period.
Figure 1: Study sample
HES=Hospital Episode Statistics for England. PEDW=Patient Episode Database for Wales. *In this research, only data for England and Wales were considered; 
data collection for Northern Ireland commenced on Feb 1, 2013, and primary and revision procedures from this country could not be considered because of their low 
number and short follow-up. Data collection for the Isle of Man commenced on July 1, 2015, which was after the endpoint of the study and therefore these data were 
not considered. †As recorded in HES for the 5 years preceding the primary knee replacement.
3659 revised for a 
periprosthetic
joint infection 
(8332 person-
years)
16 897 revised for 
another 
indication
(47 894 
person-years)
71 187 deceased 
(304 495 
person-years)
587 267 followed until 
endpoint 
Dec 31, 2014
(2 971 123 
person-years)
National Joint Registry for England, Wales, Northern Ireland
and the Isle of Man 2003–13*
679 010 primary knee replacement performed in Engand and 
Wales
74 927 surgery performed in Engand unlinked with HES 
or PEDW
40 622 surgery performed in England or Wales linked 
with PEDW
5227 surgery performed in Wales unlinked with 
PEDW
808 evidence of residency outside England†
557 426 surgery performed in England linked with HES
 
Sample used to analyse all factors except comorbidities and  ethnic
origin
Excluded from analyses including comorbidities and ethnic origin
Sample used to analyse comorbidities and ethnic origin
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n Person-
years of 
follow-up
Cases Incidence rate 
per 1000 
person-years 
(95% CI)
Patient characteristics
Sex
Female 386 047 1 913 858 1564 0·82 (0·78–0·86)
Male 292 963 1 418 437 2095 1·48 (1·41–1·54)
Age, years
<60 109 000 537 080 793 1·48 (1·38–1·58)
60–69 229 107 1 143 670 1342 1·17 (1·11–1·24)
70–79 247 636 1 233 478 1223 0·99 (0·94–1·05)
≥80 93 267 418 066 301 0·72 (0·64–0·81)
Ethnic origin
White 515 098 2 491 245 3066 1·23 (1·19–1·28)
Black African 
origin
6011 27 217 52 1·91 (1·43–2·51)
South Asian 15 510 69 500 94 1·35 (1·09–1·66)
Other and mixed 6513 28 414 40 1·41 (1·01–1·92)
Unclear 14 294 71 896 30 0·42 (0·28–0·60)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
BMI, kg/m²
<25 40 333 167 416 212 1·27 (1·10–1·45)
25–29·9 131 560 548 505 849 1·55 (1·45–1·66)
≥30 205 134 840 041 1558 1·85 (1·76–1·95)
Missing 301 983 1 776 333 1040 0·59 (0·55–0·62)
ASA grade
1 92 441 523 023 490 0·94 (0·86–1·02)
2 484 992 2 347 559 2460 1·05 (1·01–1·09)
3–5 101 577 461 713 709 1·54 (1·42–1·65)
Chronic pulmonary disease
No 478 788 2 350 416 2822 1·20 (1·16–1·25)
Yes 78 638 337 856 460 1·36 (1·24–1·49)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Diabetes
No 490 521 2 398 439 2809 1·17 (1·13–1·22)
Yes 66 905 289 833 473 1·63 (1·49–1·79)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Dementia
No 555 783 2 682 651 3274 1·22 (1·18–1·26)
Yes 1643 5621 8 1·42 (0·61–2·80)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Liver disease
No 553 389 2 672 866 3237 1·21 (1·17–1·25)
Yes 4037 15 406 45 2·92 (2·13–3·91)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Congestive heart failure
No 546 613 2 643 872 3211 1·21 (1·17–1·26)
Yes 10 813 44 399 71 1·60 (1·25–2·02)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Connective tissue–rheumatic disease
No 526 493 2 547 415 3059 1·20 (1·16–1·24)
Yes 30 933 140 856 223 1·58 (1·38–1·81)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
(Table continues in next column)
n Person-
years of 
follow-up
Cases Incidence rate 
per 1000 
person-years 
(95% CI)
(Continued from previous column)
Cancer
No 534 534 2 590 793 3170 1·22 (1·18–1·27)
Non-metastatic 
cancer
20 364 87 849 95 1·08 (0·87–1·32)
Metastatic cancer 2528 9629 17 1·77 (1·03–2·83)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Cerebrovascular disease
No 546 047 2 640 626 3221 1·22 (1·18–1·26)
Yes 11 379 47 646 61 1·28 (0·98–1·64)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Myocardial infarction
No 541 849 2 619 164 3186 1·22 (1·17–1·26)
Yes 15 577 69 107 96 1·39 (1·13–1·70)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Paraplegia and hemiplegia
No 555 229 2 678 669 3263 1·22 (1·18–1·26)
Yes 2197 9603 19 1·98 (1·19–3·09)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Peptic ulcer disease
No 549 071 2 649 116 3229 1·22 (1·18–1·26)
Yes 8355 39 155 53 1·35 (1·01–1·77)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Peripheral vascular disease
No 547 096 2 645 530 3207 1·21 (1·17–1·25)
Yes 10 330 42 742 75 1·75 (1·38–2·20)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Renal disease
No 539 605 2 628 852 3197 1·22 (1·17–1·26)
Yes 17 821 59 419 85 1·43 (1·14–1·77)
Unavailable* 121 584 644 023 377 0·59 (0·53–0·65)
Surgical characteristics
Osteoarthritis
No 18 529 92 371 157 1·70 (1·44–1·99)
Yes 660 481 3 239 923 3502 1·08 (1·05–1·12)
Trauma
No 675 193 3 313 911 3613 1·09 (1·05–1·13)
Yes 3817 18 383 46 2·50 (1·83–3·34)
Previous knee infection
No 678 522 3 329 986 3644 1·09 (1·06–1·13)
Yes 488 2309 15 6·50 (3·64–10·72)
Avascular necrosis
No 676 515 3 319 900 3638 1·10 (1·06–1·13)
Yes 2495 12 394 21 1·69 (1·05–2·59)
Inflammatory arthropathy
No 663 410 3 251 205 3534 1·09 (1·05–1·12)
Yes 15 600 81 089 125 1·54 (1·28–1·84)
Other indication
No 675 312 3 317 114 3636 1·10 (1·06–1·13)
Yes 3698 15 181 23 1·52 (0·96–2·27)
(Table continues in next column)
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Each primary replacement was followed for a minimum 
of 12 months until the end of the observation period 
(Dec 31, 2014) or until the date of revision for prosthetic 
joint infection, revision for another indication, or death 
(whichever occurred first). Revisions for prosthetic joint 
infection included debridement and implant retention 
with modular exchange, or a single-stage or two-stage 
revision procedure.20
n Person-
years of 
follow-up
Cases Incidence rate 
per 1000 
person-years 
(95% CI)
(Continued from previous column)
Surgical approach
Medial 
parapatellar
629 891 3 093 847 3 420 1·11 (1·07–1·14)
Midvastus 19 384 89 860 76 0·85 (0·67–1·06)
Lateral 
parapatellar
7992 42 506 47 1·11 (0·81–1·47)
Subvastus 9403 48 926 49 1·00 (0·74–1·32)
Other approach 12 340 57 155 67 1·17 (0·91–1·49)
Procedure
Primary TKR 
cemented
569 737 2 760 945 3227 1·17 (1·13–1·21)
Primary TKR 
uncemented
33 754 188 639 153 0·81 (0·69–0·95)
Primary TKR other 7699 48 490 52 1·07 (0·80–1·41)
Unicondylar 58 885 291 906 211 0·72 (0·63–0·83)
Patellofemoral 8935 42 314 16 0·38 (0·22–0·61)
Constraint
Unconstrained 
fixed
397 175 1 918 707 1987 1·04 (0·99–1·08)
Unconstrained 
mobile
47 532 262 875 278 1·06 (0·94–1·19)
Posterior 
stabilised fixed
144 960 705 782 981 1·39 (1·30–1·48)
Posterior 
stabilised mobile
9714 51 054 54 1·06 (0·79–1·38)
Constrained 
condylar
2968 11 498 43 3·74 (2·71–5·04)
Fixed 16 703 74 967 67 0·89 (0·69–1·14)
Mobile 41 297 212 086 141 0·66 (0·56–0·78)
Undetermined 18 661 95 326 108 1·13 (0·93–1·37)
General anaesthesia
No 381 156 1 788 490 1889 1·06 (1·01–1·10)
Yes 297 854 1 543 804 1770 1·15 (1·09–1·20)
Nerve block anaesthesia
No 547 783 2 644 393 2914 1·10 (1·06–1·14)
Yes 131 227 687 902 745 1·08 (1·01–1·16)
Epidural anaesthesia
No 621 572 2 987 043 3311 1·11 (1·07–1·15)
Yes 57 438 345 251 348 1·01 (0·90–1·12)
Spinal anaesthesia
No 283 120 1 499 422 1724 1·15 (1·10–1·21)
Yes 395 890 1 832 873 1935 1·06 (1·01–1·10)
Thromboprophylaxis regimen
Chemical 606 001 2 870 437 3204 1·12 (1·08–1·16)
Non-chemical 73 009 461 857 455 0·99 (0·90–1·08)
Femoral bone graft
No 675 147 3 317 925 3635 1·10 (1·06–1·13)
Yes 3863 14 370 24 1·67 (1·07–2·49)
Tibial bone graft
No 676 271 3 319 182 3629 1·09 (1·06–1·13)
Yes 2739 13 112 30 2·29 (1·54–3·27)
(Table continues in next column)
n Person-
years of 
follow-up
Cases Incidence rate 
per 1000 
person-years 
(95% CI)
(Continued from previous column)
Intraoperative event
No 675 089 3 314 501 3636 ··
Yes 3921 17 794 23 1·29 (0·82–1·94)
Health system characteristics
Country of surgery
England 638 835 3 136 010 3461 1·10 (1·07–1·14)
Wales 40 175 196 285 198 1·01 (0·87–1·16)
Funding
NHS 574 433 2 722 013 3091 1·14 (1·10–1·18)
Private 75 507 395 514 362 0·92 (0·82–1·01)
Unspecified 29 070 214 768 206 0·96 (0·83–1·10)
Grade of operating surgeon
Consultant 572 464 2 767 937 3032 1·10 (1·06–1·14)
Other 106 546 564 357 627 1·11 (1·03–1·20)
Consultant involvement
Operating 572 464 2 767 937 3032 1·10 (1·06–1·14)
Assisting 38 327 188 754 223 1·18 (1·03–1·35)
Not involved 68 219 375 604 404 1·08 (0·97–1·19)
Total volume (operating surgeon) of knee replacements done in previous 
12 months
≤25 173 288 988 694 1091 1·10 (1·04–1·17)
>25–50 160 104 815 890 983 1·20 (1·13–1·28)
>50–85 170 157 788 139 816 1·04 (0·97–1·11)
>85 175 461 739 571 769 1·04 (0·97–1·12)
Total volume (surgeon in charge) of knee replacements done in previous 
12 months
≤38 173 204 1 010 739 1113 1·10 (1·04–1·17)
>38–70 174 209 872 816 986 1·13 (1·06–1·20)
>70–110 162 179 730 804 791 1·08 (1·01–1·16)
>110 169 418 717 936 769 1·07 (1·00–1·15)
Total volume (hospital) of knee replacements done in previous 12 months
≤150 167 930 1 008 852 984 0·98 (0·92–1·04)
>150–285 174 288 863 114 973 1·13 (1·06–1·20)
>285–440 169 780 743 102 893 1·20 (1·12–1·28)
>440 167 012 717 227 809 1·13 (1·05–1·21)
ASA=American Society of Anesthesiologists. TKR=total knee replacement. 
NHS=National Health Service. *Information about ethnicity and comorbidities is 
only available for the 557 426 patients operated on in England with a Hospital 
Episodes Statistics record, no record in the Patient Episode Database for Wales, 
and no evidence of residency outside England. See figure 1 and appendix p 2 for 
more details.
Table: Sample description and incidence rates
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Patient characteristics21 considered were age, sex, 
ethnicity, BMI, American Society of Anesthesiologists 
(ASA) grade, and comorbidities. Ethnicity and co-
morbidities were obtained from the Hospital Episode 
Statistics records. We used International Classification 
of Diseases, 10th revision codes to classify comorbidities 
for which patients had been admitted to hospital in the 
5 years preceding their primary operation (appendix p 2).22
Surgical factors21 considered were indication for 
surgery, anaesthesia type, thromboprophylaxis regime, 
surgical approach, knee replacement type, fixation, 
degree of constraint, use of bone graft, and occurrence of 
intraoperative complications (appendix p 2).
Health-care system factors21 considered were hospital 
type, funding source (National Health Service [NHS] or 
private), country, operating surgeon grade, consultant 
involve ment, and the volume of knee surgeries (categorised 
into quartiles) done by the operating surgeon and surgeon 
in charge of the procedure in the preceding 12 months.
Statistical analysis
The associations between the risk factors and risk of 
revision for prosthetic joint infection were first investigated 
during the overall follow-up period. Poisson multilevel 
models accounting for clustering at the unit level (random 
intercept) were used. Clustering at the surgeon level was 
negligible and therefore not considered further.
Prosthetic joint infection management can vary 
according to the time elapsed since the primary procedure 
at the time of onset of infection. Early onset of infection 
(within 2 years of the primary procedure) is generally 
believed to result from the primary intervention. Later 
onset of infection (2 years or longer after the primary 
procedure) is more likely to be due to haematogenous 
spread.9 For patients with early postoperative or acute 
haematogenous infection and a short duration of 
symptoms, debridement, modular exchange, and implant 
retention rather than full revision is appropriate if the joint 
replacement is well fixed.9 The associations between risk 
factors and risk of revision were therefore re-investigated 
over several at-risk post-operative periods: 0–3 months, 
3–6 months, 6–12 months, 12–24 months, and more 
than 24 months. Each participant’s at-risk period (defined 
as the time elapsed between their primary procedure and 
the endpoint) was split according to the time spent in each 
of these periods and the revision for prosthetic joint 
infection status (revised for prosthetic joint infection vs 
not) was assigned to the relevant period. We used a 
piecewise exponential multilevel model with period-
specific effects to assess these associations—ie, their rate 
ratios (RRs) and 95% CIs across these time periods.23,24 
Analyses were done by running MLwiN from Stata 
version 14.1 using Markov Chain Monte Carlo methods.25 
To account for test multiplicity, adjusted p values were 
derived using Simes’ false-discovery rate testing controlling 
procedure.26,27 To be confident that 95% of the effects tested 
were not due to chance, evidence of association was only 
discussed for adjusted p values of up to 0·05.
The analyses were done on the overall sample for all 
exposures except for ethnicity and comorbidities, which 
were only investigated in the patients operated on in 
Sex
Male* (vs female)
Age, years
60–69* (vs <60)
70–79* (vs <60)
≥80*
BMI, kg/m2
25–29·9* (vs <25)
≥30* (vs <25)
ASA score
2* (vs 1)
3–5* (vs 1)
Comorbidity
Chronic pulmonary disease*
Diabetes*
Dementia
Liver disease*
Congestive heart failure
Connective tissue–rheumatic disease
Cancer (vs no cancer)
Metastatic cancer (vs no cancer)
Cerebrovascular disease
Myocardial infarction
Paraplegia or hemiplegia
Peptic ulcer disease
Peripheral vascular disease*
Renal disease
A
Indication
Osteoarthritis*
Trauma*
Avascular necrosis
Inflammatory arthropathy*
Other indication
Surgical approach
Midvastus (vs medical parapellator)
Lateral parapellator (vs medical parapellator)
Subvastus (vs medical parapellator)
Other approach (vs medical parapellator)
Procedure
TKR uncemented* (vs TKR cemented)
TKR other (vs TKR cemented)
Unicondylar* (vs TKR cemented)
Patellofemoral* (vs TKR cemented)
Constraint
Unconstrained mobile (vs unconstrained fixed)
Fixed posterior stabilised* (vs unconstrained fixed)
Mobile posterior stabilised (vs unconstrained fixed)
Constrained condylar* (vs unconstrained fixed)
Fixed* (vs unconstrained fixed)
Mobile* (vs unconstrained fixed)
Underterm bearing-fixation (vs unconstrained fixed)
Anaesthesia
General*
Nerve block
Epidural
Spinal*
Thromboprophylaxis regimen
Non-chemical (vs chemical)
Other events
Femoral bone graft
Tibial bone graft*
Intraoperative event
0·50 3·0 5·04·54·03·52·0 2·51·0 1·5
B
Rate ratio (95% CI)
(Figure 2 continues on next page)
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England with record of hospital admission in Hospital 
Episode Statistics, but not in the Patient Episode Database 
for Wales and no evidence of residency outside England. 
The regressions were adjusted for age, sex, ASA grade, 
and BMI. BMI is an important risk factor for prosthetic 
joint infection but has substantial missing data in the 
National Joint Registry (47%), partly because it was not 
included as a variable in the early data collection forms. A 
missing at random mechanism was assumed to account 
for observed factors associated with the propensity of 
BMI to be missing and avoid the use of a complete-case 
analysis, which would have produced biased estimates: 
mean time at risk in missing BMI group 5·9 years 
(SD 2·8) versus 4·1 years (2·3) in the complete BMI 
group; incidence of revision for prosthetic joint infection 
0·58 (95% CI 0·55–0·62) versus 1·68 (1·62–1·75); 
uncemented total knee replacement 6·0%  versus 4·1%; 
other type of total knee replacement 1·6% versus 0·8%, 
unicondylar procedure 7·9% versus 9·3%. This approach 
also allowed us to use the entire study sample and 
investigate the rare exposure, something precluded with a 
complete case approach. A multiple imputation strategy 
was used to impute BMI using a Gaussian normal 
regression imputation model with the above factors used 
as covariates as well as the log of the observed event or 
censoring time, knee replacement type, and revision 
for prosthetic joint infection status. Because of the 
computational time required by each multilevel piece wise 
model, five imputations were computed and no sensitivity 
analyses of our missing at random approach were done. 
Estimates were combined by Rubin’s rules. Unadjusted 
and adjusted models without BMI are available on 
request. To avoid over-adjustment, models investigating 
the effect of comorbidities were not adjusted for ASA 
grade, a proxy indicator of comorbidity profile.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. EL had full access to all the data in the study. 
AWB is the guarantor and had final responsibility for the 
decision to submit for publication.
Results
Baseline study sample characteristics are presented in 
figure 1 and the table. 679 010 primary knee procedures 
were done in 449 different surgical units with a median 
of 1142 procedures (IQR 564–2144) per unit. Baseline 
characteristics were assessed in all 679 010 primary knee 
procedures, except for ethnicity and comorbidities, which 
were only investigated in the 557 426 patients operated on 
in England with record of hospital admission in Hospital 
Episode Statistics, but not in the Patient Episode Database 
for Wales and no evidence of residency outside England 
(figure 1, appendix p 2). 3659 index procedures were 
subsequently revised for an indication of prosthetic 
joint infection after a median follow-up of 4·6 years 
(IQR 2·6–6·9): 245 (6·7%) of these within 3 months, 
238 (6·5%) between 3 and 6 months, 628 (17·2%) between 
6 and 12 months, 970 (26·5%) between 1 and 2 years, and 
1578 (43·1%) beyond 2 years from the index procedure. 
The median patient age was 70 years (IQR 63–76). The 
sample is presented by time periods in appendix pp 4–9. In 
792 (28%) of the 2833 two-stage revision procedures done 
for prosthetic joint infection, only a second stage procedure 
was recorded in the National Joint Registry. Patients with 
incompletely registered two-stage procedures did not differ 
from those with complete procedures and their time to 
first stage procedure was estimated (appendix p 1).
RRs of revision for prosthetic joint infection surgery 
are presented in appendix pp 10–12. Figure 2 provides 
RRs over the entire follow-up and figure 3 shows their 
effect within the first 3 postoperative months. Effects 
associated with other periods are presented in appendix 
pp 15–18.
In terms of the role of patient characteristics, men were 
at a higher risk of revision for prosthetic joint infection 
in all time periods (figure 2). During the entire follow-up, 
the risk was lower for patients aged 60 years and older 
than in patients younger than 60 years of age. Patients 
aged 80 years and older were at increased risk of early 
revision for prosthetic joint infection but were at lower 
risk of revision thereafter (appendix pp 10, 15–18). 
Patients aged 60–79 years were at reduced risk of long-
term revision for prosthetic joint infection (appendix 
pp 10, 15–18).
BMI of 30 kg/m² or higher was associated with an 
increased risk of revision for prosthetic joint infection 
Figure 2: Risk factors of revision for prosthetic joint infection during the overall postoperative period
(A) Patient factors. (B) Surgery factors. (C) Health-care system factors. Reference categories are in parentheses. 
BMI=body mass index. ASA=American Society of Anesthesiologists. TKR=total knee replacement. NHS=National 
Health Service. *Adjusted p value <0·05, detailed in appendix pp 10–12, alongside the rate ratios and 95% CIs. 
†Volume refers to the total volume of knee replacements done within the previous 12 months. 
Place of surgery
Wales (vs England)
Funding
Private (vs NHS)*
Unknown (vs NHS)
Grade of operating surgeon
Other (vs consultant)
Consultant involvement
Assisting (vs operating)
None (vs operating)
Operating surgeon volume†
25–50 (vs ≤2)
>50–85 (vs ≤2)
>85 (vs ≤2)
Volume of surgeon in charge†
38–70 (vs ≤38)
>70–110 (vs ≤38)
>110 (vs ≤38)
Hospital surgery volume†
150–285 (vs ≤150)*
>285–440 (vs ≤150)*
>440 (vs ≤150)*
0·50 3·0 5·04·54·03·52·0 2·51·0 1·5
C
Rate ratio (95% CI)
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compared with BMI lower than 25 kg/m² (figure 2), 
especially after the first year (appendix pp 10, 15–18). 
Compared with healthy patients, those with an ASA of 
2 or higher were at increased risk (figure 2), especially 
beyond 6 months for ASA 3–5 and after 2 years for ASA 2 
(appendix pp 10, 16–18).
Patients with a pre-existing history of chronic pulmonary 
disease, diabetes, liver disease, connective tissue or 
rheumatic disease, or peripheral vascular disease had a 
higher risk than those without pre-existing histories of 
these diseases (figure 2). Patients with a history of 
rheumatic disease had a higher risk of revision at most 
postoperative periods (appendix p 10). Those with liver 
disease were at higher risk of long-term revision than 
those without liver disease (appendix pp 10, 15–18). No or 
inconsistent time-specific effects were observed for the 
other comorbidities.
In terms of surgical characteristics, risk of revision 
for prosthetic joint infection varied according to the 
indication for the primary procedure. Patients operated 
on for osteoarthritis were less likely to be revised for 
prosthetic joint infection (figure 2). Those operated on 
for trauma, history of previous infection in the operated 
joint (appendix p 11), or an inflammation arthropathy 
were at increased risk of revision for prosthetic joint 
infection (figure 2), especially from 2 years post-operation 
(figure 3; appendix pp 11, 15–17). The indication for 
surgery did not affect the risk of early revision for 
prosthetic joint infection (appendix p 11). Patients 
operated on for trauma or with a history of previous 
infection were at an increased risk of revision from 1 year 
onwards (appendix pp 11, 17–18).
The risk of revision varied according to the type of 
procedure, implant fixation and constraint or bearing, 
with more extensive and complex procedures associated 
with an increased risk. Compared with cemented total 
knee replacement, patients who had an uncemented total 
knee replacement, a patellofemoral replacement, or an 
unicondylar replacement were at lower risk of revision for 
prosthetic joint infection (figure 2). From 6 months 
onwards, those with a unicondylar procedure were at 
lower risk of revision for prosthetic joint infection; the 
reduced risk of revision was observed from 1 year and 
2 years onwards respectively for patellofemoral and 
uncemented total knee replacement procedures (appendix 
pp 11, 16–18) .
The risk of revision was increased for patients with a 
posterior stabilised fixed-bearing implant or a constrained 
condylar implant compare with those with an uncon-
strained (or cruciate-retaining) fixed-bearing implant 
(figure 2): from 6 postoperative months onwards with a 
posterior stabilised fixed implant and beyond 1 year post-
surgery for a constrained condylar implant (appendix 
pp 11, 16–18). The risk of revision was lower for patients 
with fixed or mobile bearing implants, and this finding 
was particularly evident from 6 months onwards for 
mobile bearing implants (appendix pp 11, 16–18).
The risk of revision for prosthetic joint infection was 
higher for patients who had received a general anaesthetic 
or tibial bone graft, and lower for those who had received 
a spinal anaesthetic. Little or no difference in the risk of 
Sex
Male* (vs female)
Age, years
60–69* (vs <60)
70–79* (vs <60)
≥80*
BMI, kg/m2
25–29·9* (vs <25)
≥30* (vs <25)
ASA score
2* (vs 1)
3–5* (vs 1)
Comorbidity
Chronic pulmonary disease*
Diabetes*
Dementia
Liver disease*
Congestive heart failure
Connective tissue–rheumatic disease
Cancer (vs no cancer)
Metastatic cancer (vs no cancer)
Cerebrovascular disease
Myocardial infarction
Paraplegia or hemiplegia
Peptic ulcer disease
Peripheral vascular disease*
Renal disease
A
Indication
Osteoarthritis*
Trauma*
Avascular necrosis
Inflammatory arthropathy*
Other indication
Surgical approach
Midvastus (vs medical parapellator)
Lateral parapellator (vs medical parapellator)
Subvastus (vs medical parapellator)
Other approach (vs medical parapellator)
Procedure
TKR uncemented* (vs TKR cemented)
TKR other (vs TKR cemented)
Unicondylar* (vs TKR cemented)
Patellofemoral* (vs TKR cemented)
Constraint
Unconstrained mobile (vs unconstrained fixed)
Fixed posterior stabilised* (vs unconstrained fixed)
Mobile posterior stabilised (vs unconstrained fixed)
Constrained condylar* (vs unconstrained fixed)
Fixed* (vs unconstrained fixed)
Mobile* (vs unconstrained fixed)
Underterm bearing-fixation (vs unconstrained fixed)
Anaesthesia
General*
Nerve block
Epidural
Spinal*
Thromboprophylaxis regimen
Non-chemical (vs chemical)
Other events
Femoral bone graft
Tibial bone graft*
Intraoperative event
1·00 6·0 10·09·08·07·04·0 5·02·0 3·0
B
Rate ratio (95% CI)
(Figure 3 continues on next page)
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revision for prosthetic joint infection was found for other 
anaesthetic techniques, thromboprophylaxis regimen, 
use of femoral bone graft, occurrence of intraoperative 
complication, or surgical approach.
In terms of health-care system characteristics, the risk 
of revision for prosthetic joint infection did not differ 
between Wales and England (figure 2). Privately funded 
procedures had a lower risk of revision than procedures 
funded by the NHS (figure 2), especially beyond 2 years 
(appendix pp 11, 18).
Revision for prosthetic joint infection was not affected 
by the grade of the operating surgeon, the presence or 
absence of a consultant surgeon during surgery, or by the 
volume of all knee procedures done by the operating 
surgeon or the surgeon in charge (figures 2, 3, appendix 
pp 11, 15–18).
The overall risk of revision for prosthetic joint infection 
was higher in high-volume hospitals than in low-volume 
hospitals (figure 2). Compared with hospitals with a small 
volume of activity, the risk of revision was higher in the 
first 3 months after primary surgery in hospitals that had 
done more than 440 knee procedures in the year preceding 
the index surgery (figure 3). No specific difference in the 
RRs were found beyond this period or for units doing 
lower volumes of knee procedures (appendix pp 11, 15–18).
Discussion
The revision burden for prosthetic joint infection after 
knee replacement is higher than that after hip 
replacement in England and Wales.10,18 In our cohort of 
679 010 knee replacements, 3659 (0·53%) underwent 
revision for prosthetic joint infection compared with 
2707 out of 623 253 (0·43%) hip replacements studied 
during the same period.13 However, revision within the 
first 3 months is proportionately less common (6·7% of 
knee replacements had revision surgery for infection vs 
13·8% of hip replacements).
At the patient level, male patients, younger patients, 
and those with high BMI or more severe systemic disease, 
indicated by their ASA grade, had higher risk of revision 
for prosthetic join infection; however older patients (aged 
≥80 years) were at high risk of early revision for prosthetic 
joint infection. This finding might reflect a tendency to 
treat older patients non-operatively with suppressive anti-
biotics in the longer term. Comorbidities that increased 
the risk of revision for prosthetic joint infection included 
chronic pulmonary disease, diabetes, liver disease, 
connective tissue or rheumatic diseases, and peripheral 
vascular disease. Treatment of these comorbidities and 
elevated BMI can potentially be optimised before surgery. 
A targeted preoperative intervention for male patients 
with high BMI and specific comorbidities could be a 
particularly relevant approach. Long-term vigilance seems 
to be important in those with liver disease. Our patient-
level findings are concordant with the results of our study 
of infection after hip replacement,13 another large study of 
knee replacement,28 and systematic reviews.11,12 Thus, 
these results might be generalisable to a wide population 
of patients undergoing implant surgery of various types.
At the surgical level, some of our results are consistent 
with those in hip surgery, but others are not. In particular, 
different surgical approaches in knee replacement are 
not associated with revision for prosthetic joint infection, 
but the use of general anaesthetic is. In general, factors 
that are a surrogate marker for operative duration and 
complexity, such as general anaesthetic, the need for 
additional constraint, total rather than partial knee 
replacement, and the use of tibial bone grafts, are 
associated with increased risk of revision for prosthetic 
joint infection. Concordant with hip surgery and previous 
studies,11,12,28 patients undergoing joint replacement for 
trauma or inflammatory arthritis have an increased risk 
of revision for infection. This finding is unsurprising 
because inflammatory arthropathies such as rheumatoid 
arthritis and drugs used to treat these conditions, such as 
disease-modifying antirheumatic drugs are known to be 
immunosuppressive.29  The substantially higher risk of 
prosthetic joint infection in those with historical infection 
of the knee is a new finding, but again unsurprising, and 
might be due to quiescent bacteria or other immune 
conditions that predispose individuals to infection.
Factors at the health-care system level seem to be less 
important than patient or surgical characteristics, with 
no notable sustained associations across the time periods 
studied. As previously reported,28 higher volume centres 
seemed to have a higher overall risk of revision for 
prosthetic joint infection and in the early postoperative 
period, but this association was not seen in the 
Place of surgery
Wales (vs England)
Funding
Private (vs NHS)*
Unknown (vs NHS)
Grade of operating surgeon
Other (vs consultant)
Consultant involvement
Assisting (vs operating)
None (vs operating)
Operating surgeon volume†
25–50 (vs ≤2)
>50–85 (vs ≤2)
>85 (vs ≤2)
Volume of surgeon in charge†
38–70 (vs ≤38)
>70–110 (vs ≤38)
>110 (vs ≤38)
Hospital surgery volume†
150–285 (vs ≤150)*
>285–440 (vs ≤150)*
>440 (vs ≤150)*
C
Rate ratio (95% CI)
1·00 6·0 10·09·08·07·04·0 5·02·0 3·0
Figure 3: Risk factors of revision for prosthetic joint infection in the first 3 postoperative months
(A) Patient factors. (B) Surgery factors. (C) Health-care system factors. Reference categories are in parentheses. 
BMI=body mass index. ASA=American Society of Anesthesiologists. TKR=total knee replacement. NHS=National 
Health Service. *Adjusted p value <0·05, detailed in appendix pp 10–12, alongside the rate ratios and 95% CIs. 
†Volume refers to the total volume of knee replacements performed within the previous 12 months. 
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time-specific analysis or when test multiplicity was 
accounted for, indicating that this effect is not significant 
and might reflect more rapid diagnosis and early 
management of prosthetic joint infection in these 
centres. Privately funded patients were associated with 
lower long-term risks than those whose treatment was 
funded by the NHS—a finding not mirrored in our hip 
study. This difference is likely to reflect residual 
confounding with variables not available in our analysis 
because of case selection. The funding source of 
the primary procedure might therefore be a proxy for 
socioeconomic status, a patient factor not directly 
measured in the National Joint Registry.
Smoking has previously been identified as a risk factor 
for prosthetic joint infection,11,30 and, although we did not 
have information about this, the surrogate comorbidity 
of chronic pulmonary disease was associated with 
increased risk. Evidence of an association between 
alcohol intake and increased risk has been inconsistent.31,32 
We noted a higher risk in patients with liver disease, but 
this outcome might represent a number of pathologies, 
including alcohol-related liver disease, and non-alcoholic-
related disease such as fatty liver disease, hepatitis, 
haemochromatosis, or primary biliary cirrhosis. Our 
study corroborates the previous findings of increased 
risk in patients with diabetes and rheumatoid arthritis.11
The current study has several strengths. To our 
knowledge, this is the largest and most comprehensive 
evaluation of patient-related, surgical-related, and health-
care-related factors and their associations with the risk of 
revision for prosthetic joint infection of the knee. We 
used a large-scale cohort design comprising of a larger 
number of participants (>600 000) than those of the most 
up-to-date reviews on the topic (n=375 895 and n=512 508 
hip and knee replacements)11,12 or individual articles.33 
Other strengths include the long-term follow-up of the 
cohort (median 4·6 years) and advanced statistical 
analyses, which include the evaluation of the effects of 
these potential risk factors in time-specific periods, 
which is appropriate because we have demonstrated that 
risk is not constant over time. There are also several 
limitations to our study. Although prospectively collected, 
our data are observational, and we can only draw 
inferences about the nature and magnitude of the 
associations, but not establish causation. In the UK, 
no agreed national gold standards are available to 
orthopaedic surgeons for the diagnosis of prosthetic joint 
infection. As such, the reported indication for revision of 
prosthetic joint infection in the National Joint Registry 
might vary between units. The approach used to diagnose 
prosthetic joint infection is, however, reflective of 
contemporary practice, with raised inflammatory 
markers, joint-specific symptoms, sinuses, and positive 
microbiological cultures.19 The diagnosis of prosthetic 
joint infection reflects a clinical judgement sufficient to 
lead the surgeon to conduct a very severe and invasive 
procedure tailored to tackle the infection. We also 
acknowledge issues relating to under-reporting of 
revision for prosthetic joint infection, and thus potentially 
lower incidence estimates.34 Linkage of the National Joint 
Registry data to microbiology data could reduce a 
posteriori any misdiagnoses of prosthetic joint infection, 
but has been shown to be of limited generalisability, with 
only 11·8% linkage achievable.35 The associations that we 
have identified might vary with different causative 
pathogens, but unfortunately we do not have the data to 
explore this concept. Our findings should be considered 
as conservative estimates of the risk factors with the 
strongest effects. The investigation into the effects of 
comorbidities was limited to a subset of National Joint 
Registry patients linked to Hospital Episode Statistics. 
This subset had higher ASA grade and therefore higher 
rate of revision for prosthetic joint infection than those 
excluded from these investigations, but they did not 
differ in terms of age, sex, BMI, or surgical characteristics, 
suggesting little evidence of differential selection bias. 
All other factors were investigated in the entire sample.
We have done appropriate modelling to adjust for 
known relevant confounders, but the possibility of 
residual confounding does exist. We had no specific data 
about confounders such as smoking and alcohol 
consumption, but have surrogate markers for these such 
as chronic pulmonary disease and liver disease. BMI data 
were not collected in the early years of the registry, 
necessitating imputation of the missing data, as with a 
previous study on this dataset.36 The duration of surgery 
is not collected in the National Joint Registry but the 
surgical characteristics influencing revision for prosthetic 
joint infection show that this factor is likely to have an 
important role: knee replacement type, fixation, and 
constraint are all associated with the duration, and 
complexity of surgery. This has previously been shown.28 
Competing risk due to revision for another cause or 
death, which in combination affected 13% of the index 
primary knee replacements in the dataset during the 
period of observation (figure 1), could not be accounted 
for in the modelling strategy. This was a pragmatic 
decision because we chose a strategy focusing on time-
specific effects while accounting for the clustering nature 
of the data, to disentangle the effects associated with 
surgical factors (likely to be more substantial in the short-
term to mid-term follow-up) from those associated with 
health risk behaviours (likely to be more influential 
in the mid-term to long-term follow-up period). This 
strategy was optimal because there was evidence of 
non-proportional hazard rates (figure 3, appendix 
pp 15–18). Finally, it was not possible to investigate any 
ethnic disparities in terms of revision for prosthetic joint 
infection because of the small number of ethnic minority 
patients who underwent revision for prosthetic joint 
infection.
Knee replacement is an effective intervention to 
address the symptoms arising from degenerative knee 
conditions such as osteoarthritis. Although successful, 
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complications can occur and prosthetic joint infection is 
a devastating example. Strategies should therefore be 
adopted to reduce the risk of infection. Modifiable risk 
factors could be ameliorated with targeted interventions 
that could lead to a reduction in the incidence of 
prosthetic joint infection. When risk factors are not 
modifiable, they should form part of the information 
used to counsel and prepare patients for surgery and can 
form the basis of targeted follow-up and monitoring 
strategies. The time period-specific effects of the 
identified risk factors should also form an integral part of 
the preparation for and management of knee replacement 
surgery. Overall, the results of this large cohort study 
could help to better inform the practice and delivery of 
knee replacement surgery.
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